-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$25.67269.88% Upside
Annovis Bio, Inc. Frequently Asked Questions
-
What analysts cover Annovis Bio, Inc.?
Annovis Bio, Inc. has been rated by research analysts at H.C. Wainwright, EF Hutton, Canaccord Genuity in the past 90 days.